Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 106 clinical trials
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism

Primary aldosteronism (PA) is one of the most common cause of endocrine and resistant hypertension. Current studies have shown that the activation of the renin-angiotensin-aldosterone system

heart failure
hypertension
hyperaldosteronism
angiotensin
computed tomography of adrenals
  • 0 views
  • 24 Jan, 2021
  • 1 location
Dapagliflozin in Non-diabetic Stage IV CKD

. Consistently, human studies show that proteinuria is an independent predictor of progression and that its reduction is renoprotective. At comparable BP control, inhibitors of the renin-angiotensin system (RAS

hemoglobin a1c
diabetes
  • 0 views
  • 08 Dec, 2021
  • 1 location
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension

renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS) activation. Preliminary uncontrolled studies have demonstrated that in order to achieve proper control of blood pressure

  • 0 views
  • 01 Jul, 2022
  • 1 location
Lokelma for RAAS Maximisation in CKD & Heart Failure. (LIFT)

Background: CKD in patients with heart failure (HF) is common and associated with poor prognosis. Despite evidence of benefit with Renin-Angiotensin-Aldosterone-System inhibitor (RAASi) agents

aldosterone
heart failure
  • 0 views
  • 14 Mar, 2022
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

. Sodium-glucose cotransporter type-2 (SGLT2) inhibitors are antidiabetic drugs that may prevent fibrosis/cirrhosis progression by reducing hepatic steatosis/inflammation, dampening renin

  • 0 views
  • 14 Jun, 2022
  • 1 location
Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions

aiming to augment cardiac output and tissue perfusion, like upregulation of sympathetic nervous system and over-activation of the Renin Angiotensin Aldosterone System. Nevertheless, overshooting of such

vasoconstriction
aldosterone
renal impairment
angiotensin
heart failure
  • 0 views
  • 05 Aug, 2021
  • 1 location
Angiotensin Receptor Blockers in Aortic Stenosis (ARBAS)

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

ejection fraction
stenosis
  • 0 views
  • 07 Apr, 2022
  • 2 locations
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II (AIDED)

The aim of this study is to evaluate whether adding angiotensin II to the standard of care is superior compared to the standard of care alone with respect to kidney damage (personalized approach) after cardiac surgery.

angiotensin ii
vasopressor
kidney injury
  • 0 views
  • 25 Mar, 2022
  • 1 location
Prevalence of Primary Aldosteronism Among Hypertensive Patients With Atrial Arythmia

Atrial arrhythmia is the most frequent cardiac arrhythmia. It is a source of significant morbidity. Hypertension is a major risk factor for atrial arrhythmias. Primary hyperaldosteronism (PA) is a common cause of secondary hypertension, associated with a high prevalence of arrhythmias with a specific, sometimes curative, treatment. The purpose of …

aldosterone
hypertension
hyperaldosteronism
diagnostic procedure
atrial arrhythmia
  • 0 views
  • 08 Aug, 2021
  • 2 locations
Angiotensin-(1-7) and Energy Expenditure in Human Obesity

The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy expenditure and promotes markers of heat production (thermogenesis) in white adipose tissue in human obesity.

body mass index
  • 103 views
  • 19 Jun, 2022
  • 1 location